Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eaton Vance Worldwide Health Sciences Fund

+ Add to Watchlist

EIHSX:US

12.67 USD 0.17 1.32%

As of 09:29:30 ET on 01/30/2015.

Snapshot for Eaton Vance Worldwide Health Sciences Fund (EIHSX)

Year To Date: +2.10% 3-Month: +2.94% 3-Year: +28.29% 52-Week Range: 9.70 - 12.96
1-Month: +2.10% 1-Year: +25.38% 5-Year: +18.75% Beta vs SPX: 0.92

Mutual Fund Chart for EIHSX

No chart data available.
  • EIHSX:US 12.67
  • 1M
  • 1Y
Interactive EIHSX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for EIHSX

Eaton Vance Worldwide Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital growth. The Fund invests at least 80% of its net assets in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care.

Inception Date: 10-01-2009 Telephone: 1-617-482-8260
Managers: SAMUEL DAVID ISALY / SVEN H BORHO
Web Site: www.eatonvance.com

Fundamentals for EIHSX

NAV (on 2015-01-30) 12.67
Assets (M) (on 2014-12-31) 1,598.62
Fund Leveraged N
Minimum Investment 250,000.00
Minimum Subsequent Investment 0.00

Dividends for EIHSX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-16) 0.56
Dividend Yield (ttm) 15.92

Fees & Expenses for EIHSX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.02
Redemption Fee 1.00
12b1 Fee 0.00
Expense Ratio 1.21

Top Fund Holdings for EIHSX

Filing Date: 11/30/2014
Name Position Value % of Total
Bristol-Myers Squibb Co 1,230,000 72,631,500 4.450%
Amgen Inc 392,000 64,801,520 3.970%
Regeneron Pharmaceuticals Inc 153,000 63,664,830 3.900%
Intuitive Surgical Inc 119,500 61,873,515 3.791%
HCA Holdings Inc 842,000 58,678,980 3.595%
Roche Holding AG 193,000 57,753,387 3.538%
Merck & Co Inc 932,000 56,292,800 3.449%
Gilead Sciences Inc 548,200 54,995,424 3.369%
Biogen Idec Inc 177,700 54,676,513 3.350%
Actavis plc 195,300 52,850,133 3.238%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil